Review Article
Upper Tract Urothelial Carcinomas in Patients with Chronic Kidney Disease: Relationship with Diagnostic Challenge
Table 4
Detection rates of urothelial carcinomas and upper tract urothelial carcinomas in kidney transplant recipients using urological and imaging methods.
| Patients | Test | Positive result ()/total number () | Detection rate (%) | Reference |
| Urothelial carcinoma |
Urine cytology | 2/24 | 8.3% | Kao et al. [35] | 7/30 | 23.3% | Wu et al. [40] | 3/11 | 27.3% | Kliem et al. [53] | 24/21 | 66.7% | Tsaur et al. [51] | 12/16 | 75.0% | Liao et al. [37] | 22/27 | 81.5% | Li et al. [36] | Cystoscopic biopsy | 9/24 | 37.5% | Kao et al. [35] | Ureteroscopic biopsy | 12/24 | 50.0% | Kao et al. [35] | Urine cytology and abdominal ultrasound | 4/11 | 36.3% | Kliem et al. [53] | Cystoscopy and retrograde pyelography | 29/30 | 96.7% | Wu et al. [40] |
| Upper tract urothelial carcinoma |
Native kidney ultrasound | 1/11 | 9.1% | Li et al. [36] | 1/6 | 16.7% | Tsaur et al. [51] | 2/14 | 14.4% | Liao et al. [37] | 2/6 | 33.3% | Kliem et al. [53] | 15/28 | 53.6% | Wu et al. [40] | CT urography | 12/14 | 85.7% | Wang et al. [63] |
|
|
: number of patients with positive results in each diagnostic test. : number of patients who underwent each diagnostic test.
|